To elucidate the mechanisms underlining ␣3(V) collagen chain expression, we performed an initial analysis of the structure and function of the core promoter of the human COL5A3 gene. The core promoter, which lacks a typical TATA motif and has a high GC content, was defined within the ؊129 bp immediately upstream from the major transcription start site by transient transfection experiments. In this region, we identified four DNAprotein complexes, named A, B, C, and D, by a combination of DNase I footprinting and electrophoretic mobility shift assays. Electrophoretic mobility shift assays using mutant oligonucleotide revealed that the complexes A, B, C, and D bind to ؊122 to ؊117, the ؊101 to ؊96, the ؊83 to ؊78, and the ؊68 to ؊57 bp, respectively. The competition assays using consensus oligonucleotides and supershift assays with specific antibodies Vertebrate collagens, a large family of extracellular proteins, are critically important for the formation and function of virtually every organ system (1). Among them, fibrillar collagen, which includes five different molecular types I, II, III, V, and XI, participates in the formation of fibrils with molecules packed in quarter-staggered arrays (2, 3). The fibrillar collagens are divided into major types (I-III) and minor types (V and XI) based on their relative expression levels. Minor fibrillar collagen types V and XI are incorporated into the fibrils of the much more abundant collagen types I and II, respectively, and act as regulators of the sizes and shapes of the resultant heterotypic fibrils (4 -7). The collagen molecules are either homotrimers with ␣ chains or heterotrimers with two or three different ␣ chains. The predominant molecular form of type V is the heterotrimer [␣1(V)] 2 ␣2(V) and is expressed in most tissues (8). Other forms of type V collagen include the [␣1(V)] 3 homotrimer that is synthesized in cultures of hamster lung cells (9) and the ␣1(V)␣2(V)␣3(V) heterotrimer that can be extracted from the placenta (10 -12). Cross-type heterotrimer composed of ␣2(V) and ␣1(XI) chains is present in the rhabdomyosarcoma cell line A204 and bovine vitreous (13, 14) . These findings suggest that type V and type XI chains constitute a single collagen type in which different combinations of chains associate in a tissue-specific manner. Recently, a fourth chain, ␣4(V), expressed in rat Schwann cells was reported (15). This ␣ chain, which can form molecules with ␣1(V) and ␣2(V) chains, seems to be the counterpart of the mouse and human ␣3(V) chain (16).
Vertebrate collagens, a large family of extracellular proteins, are critically important for the formation and function of virtually every organ system (1) . Among them, fibrillar collagen, which includes five different molecular types I, II, III, V, and XI, participates in the formation of fibrils with molecules packed in quarter-staggered arrays (2, 3) . The fibrillar collagens are divided into major types (I-III) and minor types (V and XI) based on their relative expression levels. Minor fibrillar collagen types V and XI are incorporated into the fibrils of the much more abundant collagen types I and II, respectively, and act as regulators of the sizes and shapes of the resultant heterotypic fibrils (4 -7) . The collagen molecules are either homotrimers with ␣ chains or heterotrimers with two or three different ␣ chains. The predominant molecular form of type V is the heterotrimer [␣1(V)] 2 ␣2(V) and is expressed in most tissues (8) . Other forms of type V collagen include the [␣1(V)] 3 homotrimer that is synthesized in cultures of hamster lung cells (9) and the ␣1(V)␣2(V)␣3(V) heterotrimer that can be extracted from the placenta (10 -12) . Cross-type heterotrimer composed of ␣2(V) and ␣1(XI) chains is present in the rhabdomyosarcoma cell line A204 and bovine vitreous (13, 14) . These findings suggest that type V and type XI chains constitute a single collagen type in which different combinations of chains associate in a tissue-specific manner. Recently, a fourth chain, ␣4(V), expressed in rat Schwann cells was reported (15) . This ␣ chain, which can form molecules with ␣1(V) and ␣2(V) chains, seems to be the counterpart of the mouse and human ␣3(V) chain (16) .
Type V collagen, which is widely expressed spatially and temporally, is expressed in the mouse embryo as early as 11 days post-coitum (17) . Altered production of type V collagen is associated with some connective tissue pathology, such as inflammation, some forms of cancer, and atherosclerosis (18 -20) . Characterization of the cis-acting elements and trans-acting nuclear factors that modulate correct patterns of gene expression is necessary for understanding physiological and pathological conditions. Among the collagen genes, the transcriptional regulation of type I collagen has been most extensively studied, showing common features of the proximal promoter and tissue-specific enhancer (21, 22) . With regard to minor collagen, Penkov et al. (23) identified the nuclear factors binding to the proximal promoter of COL5A2. Their results indicate that members of the homeotic complex and TALE class of homeoproteins, PBX1/2, PREP1, and HOXB1, were involved in regulation of COL5A2. B-myb, a member of the myb gene family, indirectly repressed the COL5A2 gene promoter by interacting with the positive factor that binds to the first exon (24) . Lee and Greenspan (25) suggested that the GAGA boxes in the promoter and the first exon of the COL5A1 gene affect the transcription. We have recently characterized the proximal promoter of the COL11A1 (26) and Col5a1 genes (27) . In these studies, we demonstrated that the CCAAT binding factor, CBF/ NF-Y, bound to the CCAAT motif in the proximal promoter and is involved in activation of the genes.
Recently, human and mouse full-length pro-␣3(V) sequences were provided (16) . These were shown to be closely related to the pro-␣1(V) chain. In situ hybridization of mouse embryo detected its expression in epimysial sheaths of developing muscles and within nascent ligaments adjacent to forming bones and in joints, where it probably forms molecules with ␣1(V) and ␣2(V). In the present study, we cloned the human promoter DNA fragment and characterized the core promoter of the ␣3(V) collagen gene. DNase I footprinting and DNA binding assays have demonstrated four nuclear protein binding sites in the promoter region. Cell transfection experiments showed that one works as an activator and two as repressors. Finally, functional analysis combined with oligonucleotide competition and supershift assays showed that CBF/NF-Y acts as a transcriptional activator of COL5A3.
MATERIALS AND METHODS
Cells and Cell Culture Conditions-Most of the cell lines used in this study were purchased from the American Type Culture Collection (ATCC) and the Japanese Collection of Research Bioresources (JCRB) cell banks. A204 cells (human embryonal rhabdomyosarcoma cell line, ATCC HTB-82), HT-1080 cells (human fibrosarcoma cell line, ATCC CCL-121), U251MG cells (human glioblastoma cell line, JCRB, IFO50288), IMR32 cells (human neuroblastoma cell line, ATCC CCL-1277), and A498 cells (human epithelial cell line, ATCC HB-44) were cultured in Dulbecco's modified Eagle's medium containing 10% heatinactivated fetal bovine serum (Sanko Junyaku, Tokyo, Japan) at 37°C in a 5% CO 2 /air environment. Jurkat cells (human T cell line, ATCC TIB-152) and YST-1 cells, a primary cell line of human Schwannoma cells (kindly provided by Dr. Y. Nagashima, Yokohama City University School of Medicine), were cultured in RPMI 1640 medium containing 10% fetal bovine serum in the same environment.
Isolation of RNA-Total RNA was isolated from cultured cells using Isogen (Nippon Gene Co. Ltd., Tokyo, Japan) according to the manufacturer's instructions. RNA was quantified by optical density (A 260 ) and stored at Ϫ80°C until used.
Reverse Transcription-Polymerase Chain Reaction (RT 1 -PCR)-The expression of COL5A3 mRNA in various cell lines was investigated by RT-PCR. Three micrograms of total RNA was reverse transcribed by random hexamer priming using SuperScript II reverse transcriptase (Invitrogen). The single-stranded cDNA was amplified by PCR using COL5A3-specific primer pairs and glyceraldehide-3-phosphate dehydrogenase primers. The primers are listed in Supplemental Materials Table S1 .
PCR was carried out for 30 cycles using a step cycle of 94°C for 30 s, 55°C for 20 s, 72°C for 30 s, followed by 72°C for 7 min. The PCR products were analyzed by electrophoresis on a 4% ethidium bromidestained agarose gel. The amplified fragment was eluted from the gel and subcloned into the pGEM-T Easy vector (Promega) for sequencing.
Screening Human BAC Library and Cloning of Genomic DNA Fragment-A human genomic BAC library was screened to obtain the COL5A3 genomic fragment using the PCR protocol supplied by the manufacturer (Genome System, Inc., St. Louis, MO). The primers specific for the COL5A3 used in the PCR-based screening are listed in Supplemental Materials Table S1 .
The DNA from the PCR-positive BAC clone was purified and the sequences at both ends were determined by a direct sequencing method using Sp6 and T7 primers specific for the BAC cloning vector arms. The sequences were compared with those in the EMBO/GenBank TM data base. To obtain a smaller DNA fragment that contains the promoter region of COL5A3, the DNA was digested with ApaI because this restriction site was located just upstream of the initiating ATG codon. The resulting fragments were subcloned into the pBluescript (SKϩ) vector. The sublibrary was screened by colony hybridization.
Rapid Amplification of 5Ј-cDNA Ends (5Ј-RACE)-The 5Ј-RACE experiment was carried out according to the method described by Frohman et al. (28) . Briefly, 10 g of total RNA from A204 or YST-1 cells was reverse transcribed using the COL5A3-specific primer, RACE1 or RACE3 (Fig. 2C) . Homopolymeric dC was added to the 3Ј-end of the first strand cDNA using terminal deoxynucleotidyl transferase in the presence of dCTP. The dC-tailed cDNA was amplified with PCR using a poly(dG) containing the 5Ј adapter primer and a 3Ј COL5A3-specific primer, RACE2 or RACE4, which was located just upstream of RACE1 or RACE3, respectively (Fig. 2C) . PCR was carried out for 35 cycles using a step cycle of 94°C for 1 min, 55°C for 1 min, 72°C for 2 min, followed by 72°C for 8 min. The 5Ј-RACE products were purified by electrophoresis on a 4% ethidium bromide-stained agarose gel, and then subcloned into the pGEM-T Easy vector for sequencing.
In Vitro Transcription and RNase Protection Assay-RNase protection assays were carried out to confirm the transcription initiation sites. A 252-bp genomic fragment, containing putative transcription initiation sites from the data of the 5Ј-RACE experiment, was generated by PCR. This PCR product was subcloned into pGEM-T Easy vector, followed by digestion with EcoRI, and subcloned into the EcoRI site of pBluescript (SKϩ) vector. After linearization with BamHI, the antisense riboprobe was synthesized using the in vitro transcription kit, MAXIscript (Ambion, Austin, TX), according to the manufacturer's instructions. This riboprobe was examined by 5% polyacrylamide gel containing 8 M urea, and the full-length riboprobe was recovered from the gel. RNase protection analysis was performed using a ribonuclease protection assay kit, RPAIII (Ambion), following the manufacturer's protocol. Briefly, 20 g of total RNA isolated from A204 or YST-1 cells and 8 ϫ 10 4 cpm of riboprobe were dissolved in 10 l of hybridization buffer and incubated overnight at 42°C. After digestion with the RNase A/T1 mixture, protected RNA fragments were separated on a 6% polyacrylamide gel containing 8 M urea. As a size marker, 32 P-end-labeled X174 DNA/HaeIII marker was loaded onto the same gel. After the run had finished, the gel was transferred onto 3MM paper (Whatman) and dried under vacuum. The dried gel was visualized by autoradiography using a Bio Imaging Analyzer FLA-5000 (Fuji Film, Tokyo, Japan).
Construction of Chimeric Plasmids-The ApaI genomic fragment corresponding to the region from Ϫ1785 to ϩ112 bp of the COL5A3 was blunt-ended with T4 DNA polymerase and subcloned into the SmaI site of pGL3-Basic vector (Promega). To generate the 5Ј stepwise deletion constructs, PCR procedures were applied. PCR was performed using sets of oligonucleotide primers that are SacI sitelinked 5Ј and HindIII site-linked 3Ј primers specific for the COL5A3 sequence and the pGL3Ϫ1785/ϩ109 plasmid as a template. These PCR products were subcloned into the pGEM-T Easy vector, followed by digestion with SacI and HindIII, and subcloned into the SacI/ HindIII site of pGL3-Basic vector.
Internal deletion and substitution mutation constructs were generated by site-directed mutagenesis using the pGL3Ϫ310/ϩ109 plasmid as a template. The primers used in the PCR amplification are listed in Supplemental Materials Table S1 . The PCR products were digested with endonuclease, followed by self-ligation. All mutagenesis plasmids were digested with SacI and HindIII and re-cloned into the SacI/ HindIII site of pGL3-Basic vector. Construction of the dominant negative CBF-B/NF-YA was generated by RT-PCR as previously described (26, 29) .
Transient Transfection and Luciferase Assays-Transient transfection experiments were carried out using A204 and YST-1 cells. The cells were plated at a density of 2 ϫ 10 5 per 35-mm dish ϳ18 h before transfection. For transient transfection, 1 g of plasmid DNA was transfected into these cells by using the LipofectAMINE Plus reagent system (Invitrogen). Plasmid pRL-TK vector (Promega) was always cotransfected as an internal control for transfection efficiency. After an additional cultivation for 48 h, the transfected cells were harvested, lysed, centrifuged to pellet the debris, and subjected to luciferase assay. Luciferase activities were measured as chemiluminescence in a luminometer (Lumat LB 9507, PerkinElmer Life Sciences) using the Dual Luciferase Reporter Assay System (Promega) according to the manufacturer's protocol. The cotransfection experiments with a mutant type of CBF-B/NF-YA subunit expression vector were performed as previously described (26, 27) . All transfections were repeated in triplicate and the results were expressed as the mean Ϯ S.D. of three independent experiments.
Preparation of Nuclear Extracts-Nuclear extracts from A204 and YST-1 cells were prepared according to the method of Dignam et al. (30) . Briefly, cells, 1 ϫ 10 8 , were scraped in ice-cold phosphate-buffered saline (PBS), centrifuged for 5 min at 1,500 ϫ g, and washed with PBS before being recentrifuged. The pellets were resuspended in buffer (10 mM HEPES, pH 7.8, 10 mM KCl, 0.1 mM EDTA, 0.1% Nonidet P-40), incubated on ice for 10 min, and homogenized. Nuclei were pelleted by centrifugation at 3,000 ϫ g for 10 min at 4°C, followed by resuspension in buffer (50 mM HEPES, pH 7.8, 420 mM KCl, 5 mM MgCl 2 , 0.1 mM EDTA, 20% glycerol) and mixed by rotation at 4°C for 1 h. After centrifugation at 24,000 ϫ g for 30 min at 4°C, the supernatants were collected and stored at Ϫ80°C until used. The protein concentration of the nuclear extracts was determined by Bradford assay (Bio-Rad) using bovine serum albumin as a standard.
DNase I Footprinting Assay-Probes for DNase I footprinting were generated by PCR amplification using sets of oligonucleotides that are SacI site-linked 5Ј and HindIII site-linked 3Ј primers specific for COL5A3, and all PCR products were subcloned into the pGEM-T Easy vector. These plasmids were digested with HindIII and radiolabeled with [␣-32 P]dCTP using Klenow fragment to fill in the HindIII overhanging sites. After digestion with SacI, these probes were examined by a 4.5% non-denaturing polyacrylamide gel and 3Ј end-labeled probes were recovered from the gel. DNase I footprinting was performed according to the protocol described by Galas and Schmitz (31) with some modifications. Briefly, the 3Ј end-labeled probe (50,000 cpm) was incubated at 25°C for 30 min with 50 g of nuclear extracts (or bovine serum albumin as control) in a 100-l reaction mixture containing 20 mM Tris-HCl (pH 7.9), 3 mM MgCl 2 , 100 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, 5 g of bovine serum albumin, and 4 g of poly(dI-dC). After the addition of 5 units of DNase I (or 0.1 unit with bovine serum albumin as control) to the mixture, the incubation was continued for 5 min at 25°C. The reaction was stopped by adding 100 l of a stop buffer (200 mM sodium acetate, 20 mM EDTA, 1% SDS, 10 g of yeast tRNA), and DNA fragments were subsequently extracted with phenol/chloroform and precipitated with ethanol before being loaded onto a 6% polyacrylamide gel containing 8 M urea. After electrophoresis, the gel was transferred onto 3 MM paper, dried, and exposed to a BioImaging Analyzer FLA-5000.
Electrophoretic Mobility Shift Assay (EMSA)-Wild-type and mutant probes used for EMSA were generated by PCR using each set of HindIII site-linked primers, and all PCR products were subcloned into the pGEM-T Easy vector. All plasmids were digested with HindIII and the digested fragments were radiolabeled with [␣-32 P]dCTP using Klenow fragment to fill in the HindIII overhanging sites. The binding reaction was carried out for 30 min at 25°C in 25 l of binding buffer (50 mM HEPES, pH 7.8, 250 mM KCl, 25 mM MgCl 2 , 5 mM EDTA, 50% glycerol) containing 20,000 -30,000 cpm of labeled probe, 3 g of poly(dI-dC), and 5-15 g of nuclear extracts. For the competition assays, double strand oligonucleotides containing a consensus CBF, CBF mutant, NF-1, CEBP, GATA-1, c-Myb, and MEF-1 binding site were generated by annealing equimolar complementary oligonucleotides. The consensus sequences are shown in Fig. 7A . For the supershift assay, anti-CBF-A/ NF-YB, anti-CBF-B/NF-YA, anti-CBF-C/NF-YC, anti-NF-1, anti-CEBP, and anti-GATA-1 polyclonal antibodies and preimmune goat IgG (Santa Cruz Biotechnology, Santa Cruz, CA) were purchased. For these interference assays, 5-100-fold molar excess of unlabeled competitor or 2 g of antibody was added to the reaction mixture for 1 h at 4°C before the addition of radiolabeled probe. The DNA-protein complexes were separated on a 4.5% non-denaturing polyacrylamide gel in a 0.25ϫ Tris borate electrophoresis buffer at 200 V. Following completion of running, the gel was transferred onto 3MM paper and dried under vacuum. The dried gel was visualized by autoradiography using a BioImaging Analyzer FLA-5000.
Chromatin Immunoprecipitation (CHIP) Assay-CHIP assays were performed using a chromatin immunoprecipitation assay kit (Upstate Biotechnology, Lake Placid, NY) according to the manufacturer's protocol. Briefly, A204 and YST-1 cells were inoculated at a density of 5 ϫ 10 6 per 100-mm dish. The cells were fixed in a final concentration of 1% formaldehyde for 10 min at room temperature. After washing twice with PBS, cells were removed from dishes in PBS containing 1 mM EDTA, and harvested by centrifugation at 1,000 ϫ g for 1 min at 4°C. The cell pellets were resuspended in SDS lysis buffer, incubated for 10 min at 4°C, and sonicated four times for 10 s yielding DNA fragments 200 -1000 bp in size. After centrifugation, the supernatant was diluted in CHIP dilution buffer, precleared with salmon sperm DNA/protein A-agarose slurry, and immunoprecipitated with the indicated antibodies overnight at 4°C. Immunocomplexes were captured on the ssDNA/ protein A-agarose slurry, and washed with low salt wash buffer, high salt wash buffer, and LiCl wash buffer and finally washed twice with TE buffer. The immunocomplexes were eluted by incubation for 15 min at 25°C with 200 l of elution buffer (1% SDS, 100 mM NaHCO 3 , 1 mM dithiothreitol). To reverse the cross-linking of DNA, the elutes were treated with 8 l of 5 M NaCl and incubated for 4 h at 65°C, followed by treatment with proteinase K for 1 h at 45°C. The DNA fragments were extracted with phenol/chloroform and precipitated with ethanol. PCR were carried out for 40 cycles using a step cycle of 94°C for 30 s, 55°C for 20 s, 72°C for 30 s, followed by 72°C for 8 min. The PCR products were analyzed by electrophoresis on a 4% ethidium bromide-stained agarose gel.
DNA Sequencing-Nucleotide sequences were determined by automated DNA sequencing (ABI PRISM 310 Genetic Analyzer, Applied Biosystems, Foster, CA) using the BigDye Terminator Cycle Sequencing Kit (Applied Biosystems).
RESULTS

RNA Expression of COL5A3 in Cultured
Cells-Initially, we examined the expression of the COL5A3 in various culture cells using the RT-PCR technique. As shown in Fig. 1 , the predicted band of 295 bp was observed in YST-1 (strong) and A204 (weak) cells. The PCR products were verified by nucleotide sequence to confirm the specificity of the amplified COL5A3 sequence. By contrast, the band was not detected in HT1080, Jurkat, U251MG, IMR32, and A498 cells. From these results, we decided to use A204 and YST-1 cell lines for the analysis of the COL5A3 promoter.
Structural Analysis of the 5Ј Portion of COL5A3-To obtain the COL5A3 genomic fragment, we screened a human genomic BAC library by PCR, and isolated one positive clone, 218M16. Compared with the EMBO/GenBank TM data base, DNA sequences of both ends of the clone were identical with those of two clones, AC008742 and AC020931, in chromosome 19 of Homo sapiens. From the data base, this BAC genomic fragment, which was ϳ141 kb in size, contained the promoter region and both exons and introns 1-32 of COL5A3 (Fig. 2A) . To subclone a DNA fragment containing the promoter region, the BAC genomic fragment was digested with ApaI endonuclease and subcloned into the pBluescript (SKϩ) vector. The sublibrary was screened by colony hybridization and the insert DNA of the positive clone was sequenced using COL5A3-specific or vector-specific primers. As a result, a 1897-bp genomic fragment containing the 5Ј-flanking region of COL5A3 was isolated (Fig. 2B) .
To determine the transcription initiation sites of COL5A3, 5Ј-RACE experiments and RNase protection assays were performed. The 5Ј-RACE was carried out using total RNA derived from A204 and YST-1 cells. Sixteen independent clones, eight clones from A204 cells and eight clones from YST-1 cells, were selected and sequenced. As shown in Fig. 2C , the 5Ј-ends of the COL5A3 cDNA were located at 113 to 119 bp upstream from the initiating ATG codon, and 13 of the 16 RACE products were generated from the same position, which suggested that the major transcription initiation site is located 119 bp upstream from the initiating ATG codon. On the basis of these data, we also performed RNase protection assays to confirm the transcription initiation sites. In this experiment, we used a 357-nucleotide riboprobe spanning nucleotides containing the putative transcription initiation site, and at least two specific protected bands were observed in both A204 and YST-1 cells (Fig. 2D) . The protected bands were about 115 and 100 nucleotides in size, and the larger protected band corresponded to the results of the 5Ј-RACE. Therefore, we concluded that COL5A3 contains at least two transcription initiation sites and that the major transcription initiation site is located 119 bp upstream from the initiating ATG codon. The COL5A3 promoter also lacks a canonical TATA box and has a high GC content.
Functional Analysis of the COL5A3 Promoter Region-To define the proximal regulatory regions in the COL5A3 promoter, a series of chimeric constructs containing progressive 5Ј end and internal deletions linked to the luciferase gene were transfected into A204 and YST-1 cells (Fig. 3A) , and luciferase assays were carried out. The longest construct, pGL3Ϫ1785/ ϩ109, derived from a 1.9-kb genomic fragment of the 5Ј-flanking region of COL5A3, had strong transcriptional activity. The activity of each construct was compared with this construct. As shown in Fig. 3B , deletion from Ϫ1785 to Ϫ129 bp had no significant change on luciferase activity; however, deletion to Ϫ40 bp resulted in a significantly lower luciferase activity compared with that of pGL3Ϫ1785/ϩ109, and deletion to the ϩ3 bp showed almost complete loss of luciferase activity in both A204 and YST-1 cells. In addition, the deletion mutant of pGL3Ϫ310/ϩ109(delϪ129/ϩ2), which is deleted between Ϫ129 and ϩ2, also showed a significantly lower luciferase activity in both cells. These results indicate that the region between the Ϫ129 and ϩ2 bp is important for basal transcriptional activity of the COL5A3 promoter. 
Identification of Nuclear Factor Binding Sites in the Core
Promoter of the COL5A3-To identify transcription factor binding sites on the proximal promoter region of COL5A3, we initially performed DNase I footprinting. Two different probes, which contain the region from the Ϫ160 to Ϫ51 bp (Fig. 4A) and from the Ϫ96 to ϩ30 bp (Fig. 4B) , were used in this experiment. As shown in Fig. 4, A and B , two protected regions, FP (footprint) 1 in the Ϫ124 to Ϫ117 bp, and FP2 in the Ϫ69 to Ϫ63 bp regions, were observed in the COL5A3 promoter.
To further investigate the binding of nuclear proteins to the proximal COL5A3 promoter, we carried out EMSA experiments. From the footprinting data, we prepared three overlapping oligonucleotides covering the region between Ϫ160 and Ϫ51 bp (Fig. 5) . The Ϫ160/Ϫ101wt probe, covering the Ϫ160 to Ϫ101-bp region, which contains the FP1 site, could bind nuclear protein extracted from A204 and YST-1 cells in a dosedependent manner (Fig. 6A) . The band was competitively inhibited by corresponding excess unlabeled oligonucleotide (Fig.  6B) . We prepared two substitution oligonucleotides, Ϫ160/ Ϫ101m2 and Ϫ160/Ϫ101m1 (Fig. 5) . The former was mutated at the FP1 site and the latter at a site unrelated to FP1 region. As shown in Fig. 6A , the Ϫ160/Ϫ101m2 probe could not form a DNA-protein complex, whereas the Ϫ160/Ϫ101m1 probe could in A204 and YST-1. Furthermore, this DNA-protein complex A disappeared completely in the presence of 100-fold excess of unlabeled Ϫ160/Ϫ101m1 probe, but not in the presence of excess unlabeled Ϫ160/Ϫ101m2 probe (Fig. 6B) .
Although a protected region was not observed in DNase I footprinting between positions Ϫ115 and Ϫ71 bp, the Ϫ115/ Ϫ71wt probe could bind nuclear proteins extracted from A204 and YST-1 cells, and three and two DNA-protein complexes were observed in A204 cells and YST-1 cells, respectively (Fig.  6C, lanes 1 and 10) . To clarify whether these complexes were specific or not, we carried out EMSA experiments using unlabeled Ϫ115/Ϫ71wt probe and salmon sperm DNA (ssDNA) as competitors. The three DNA-protein complexes in A204 cells were competed out in the presence of the unlabeled Ϫ115/ Ϫ71wt probe in a dose-dependent manner (Fig. 6C, lanes 2-5) , whereas the upper DNA-protein complex was abolished in the presence of only a 5-fold excess ssDNA (Fig. 6C, lane 6) . The middle and lower complexes remained even in the presence of 100-fold excess ssDNA (Fig. 6C, lane 9) . We concluded that the middle and lower DNA-protein complexes are specific but the upper complex is nonspecific in A204 cells. On the other hand, the two DNA-protein complexes of YST-1 cells did not disappear in the presence of ssDNA (Fig. 6C, lanes 15-18) . These results showed two nuclear protein binding sites between the Ϫ115 and Ϫ71 bp of the COL5A3 promoter. To verify these nuclear protein binding sites, we prepared substitution mutation probes, Ϫ115/Ϫ71m3, -m4, -m5, and -m6 (Fig. 5) , and carried out EMSA experiments. As shown in Fig. 6D , the Ϫ115/ Ϫ71m3 and Ϫ115/Ϫ71m6 probes could not form the DNAprotein complexes B and C, respectively.
The position from Ϫ80 to Ϫ51 bp contained the FP2-protected site. As shown in Fig. 6E , the Ϫ80/Ϫ51wt probe could bind nuclear proteins extracted from A204 and YST-1 cells (lanes 1 and 10) , and two and one DNA-protein complexes were observed in A204 cells and YST-1 cells, respectively. From the competition analysis, the upper DNA-protein complex observed in A204 cells was abolished in the presence of a 10-fold excess of ssDNA (lane 7), although the lower complex was not competed out in the presence of 100-fold excess ssDNA (lane 9). We concluded that the lower band, DNA-protein complex D, existed between the Ϫ80 and Ϫ51 bp. As shown in Fig. 6F , Ϫ80/Ϫ51 m7 mutation probe (Fig. 5 ) could form the DNAprotein complex D, but Ϫ80/Ϫ51m8 and -m9 probes could not. These results were consistent with the result of the DNase I footprinting analysis.
Identification of Nuclear Factors in the Core
Promoter of COL5A3-To identify the nuclear binding proteins in the core promoter of the COL5A3, we performed a computer analysis (transfac.gbf.de/TRANSFAC/). The FP1 site, where a protein binds to form complex A, has the CCAAT motif that is recognized by transcription factors such as CBF/NF-Y, NF-1, CEBP, and GATA-1 (Figs. 2C and 7A) . The binding site for DNAprotein complex B contained putative transcription factor-binding sites for c-Myb and CEBP and that of complex C was consistent with E-box (Figs. 2C and 7A) . However, at the FP2 site, where a protein binds to form complex D, a known factor could not be identified. As shown in Fig. 7B , an excess of the consensus oligonucleotides of CBFwt inhibited the binding of the Ϫ160/Ϫ101wt probe, whereas NF-1, CEBP, GATA-1 consensus, and CBFmt oligonucleotides could not abolish the binding activity. On the other hand, c-Myb and CEBP, and MEF-1 consensus oligonucleotides could not compete out complexes B and C, respectively (Fig. 7C) .
To confirm the binding of CBF/NF-Y to the CCAAT motif, we performed an interference assay using specific antibodies. As shown in Fig. 8 , DNA-protein complex A was only supershifted by anti-CBF/NF-Y antibodies, namely anti-CBF-A/NF-YB, CBF-B/NF-YA, and CBF-C/NF-YC, but not by other specific antibodies against NF-1, CEBP, and GATA-1, and control IgG. To examine whether CBF/NF-Y binds directly to COL5A3, we performed a CHIP assay. DNA-protein complexes were immunoprecipitated with antibodies, the cross-links reversed, and recovered DNA fragments were monitored by PCR using primers for the Ϫ200 to ϩ109 bp region of the COL5A3 gene. As shown in Fig. 9 , DNA fragments immunoprecipitated with polyclonal antibodies against CBF/NF-Y could be amplified by PCR using the indicated primers (lane 5) as well as the positive control (lane 2), whereas those immunoprecipitated with normal IgG (lane 4) or without antibody (lane 3) could not. These results indicate that CBF/NF-Y binds specifically to the CCAAT motif in the COL5A3 core promoter, in vivo.
The CBF/NF-Y and Two Repressors Regulate the Core Promoter of COL5A3-From the DNase I footprinting and EMSA analysis, four nuclear protein binding sites were identified between Ϫ160 and Ϫ51 bp. To clarify whether these nuclear protein binding sites were functional, a series of substituted mutations of a luciferase construct (Fig. 10A) were transfected into A204 and YST-1 cells and luciferase assays were carried out. The activity of each construct was compared with that of pGL3Ϫ310/ϩ109wt. As shown in Fig. 10B , the activity of the pGL3Ϫ310/ϩ109m2 construct was suppressed, whereas those of pGL3Ϫ310/ϩ109m3 and -m6 constructs increased in both A204 and YST-1 cells. On the other hand, the activities of the pGL3Ϫ310/ϩ109 m8 and m9 constructs did not change compared with that of the pGL3Ϫ310/ϩ109wt construct. These results show that the nuclear protein binding factor of DNAprotein complex A, namely CBF/NF-Y, activates the COL5A3 promoter and those of complex B and C suppress. Consistent with these data, overexpression of the dominant-negative CBF-B/NF-YA subunit, which interacts with the CBF-A/NF-YB and CBF-C/NF-YC subunits to form CBF/NF-Y (27) , suppressed the promoter activity in both A204 and YST-1 cells by ϳ30% (p Ͻ 0.05) (Fig. 11 ).
DISCUSSION
The cloned 1.9-kb genomic fragment from the 5Ј-flanking region of COL5A3 had strong transcriptional activity. The promoter has multiple transcriptional start sites, lacks the canonical TATA box around Ϫ30 bp from the major transcriptional start site, and has a high GC content. These structural features are characteristic for the promoter of housekeeping genes. To define the proximal regulatory regions in the COL5A3 promoter, a series of chimeric constructs containing progressive 5Ј end and internal deletions linked to the luciferase gene were transfected into A204 and YST-1 cells. The region from Ϫ129 to ϩ2 bp was necessary for the basal transcriptional activity of COL5A3. With the combination analysis using footprinting and EMSA, we identified four nuclear protein binding sites located between the Ϫ160 and Ϫ51 bp. Among them, we demonstrated that CBF/NF-Y bound to the CCAAT motif in the Ϫ122 to Ϫ117-bp region and acts as an activator, and the factors located in the Ϫ101 to Ϫ96 bp and in the Ϫ83 to Ϫ78-bp regions act as repressors.
Transcription of collagen genes is controlled by a series of complex interactions of positive and negative transcription factors. A number of regulatory elements required for constitutive and inducible expressions have been identified in the promoter of both type I collagen genes (21, 22) . The previous studies have identified the ubiquitous factors, Sp1 and Sp3, and CBF/NF-Y and competitor (lane 1), and with nuclear extracts but without competitor (lanes 2 and 6) . C, competition analysis using an excess of unlabeled oligonucleotides. The 32 P-labeled Ϫ115/Ϫ71wt probe was incubated with nuclear extracts from A204 and YST-1 cells in the presence of 5-, 10-, 20-, and 100-fold excess of unlabeled Ϫ115/Ϫ71wt oligonucleotide (lanes 2-5 and 11-14) and ssDNA (lanes 6 -9 and 15-18) as competitors. The specific DNA-protein complexes are indicated by B and C with arrows, and nonspecific complex (N.S.) is indicated by an asterisk. D, binding assay using 6-bp substituted mutation probes. The 32 P-labeled Ϫ115/Ϫ71wt, -m3, -m4, -m5, and -m6 probes were incubated with nuclear extracts from A204 (lanes 1-5) and YST-1 cells (lanes 6 -10) . E, competition analysis using an excess of unlabeled oligonucleotides.
32 P-Labeled Ϫ80/Ϫ51wt probe was incubated with nuclear extracts from A204 and YST-1 cells in the presence of 5-, 10-, 20-, and 100-fold excess of unlabeled Ϫ80/Ϫ51wt probe (lanes 2- 5 and 11-14) and ssDNA (lanes 6 -9 and 15-18) as competitors. The specific DNA-protein complex is indicated by D with an arrow, and the nonspecific complex (N.S.) is indicated by an asterisk. F, binding assay using 6-bp substituted mutation probes. The 32 P-labeled Ϫ80/Ϫ51wt, -m7, -m8, and -m9 probes were incubated with nuclear extracts from A204 (lanes 1-4) and YST-1 cells (lanes 5-8) .
binding factors for basal activity of these promoters (32) (33) (34) (35) (36) (37) . Other putative transcription factors such as c-Krox, BFCOL1, and IF-1 are also involved in the transcriptional regulation of type I collagen genes (38 -40) . In COL5A3, we demonstrated that CBF/NF-Y and two repressors are involved in the regulation of the core promoter. CBF/NF-Y was originally identified as the proteins bound to the major histocompatibility complex class II conserved Y box in Ea promoters and the yeast CYC1
tracts from A204 and YST-1 cells in the presence of 100-fold excess unlabeled CBFwt (lanes 2 and 8), CBFmt (lanes 3 and 9) , NF-1 (lanes 4 and 10), CEBP (lanes 5 and 11), and GATA-1 (lanes 6 and 12) . Lanes 1 and 7 were performed without competitor. C, competition analysis using various consensus oligonucleotides as competitors. The 32 P-labeled Ϫ115/Ϫ71wt probe was incubated with nuclear extracts from A204 and YST-1 cells in the presence of 100-fold excess competitors, ssDNA (lanes 2 and 8) , Ϫ115/Ϫ71wt (lanes 3 and 9) , c-Myb (lanes 4 and  10), CEBP (lanes 5 and 11) , and MEF-1 (lanes 6 and 12) . Lanes 1 and 7 were performed without competitor. 4, 12, 21, and 25) , anti-CBF-C/NF-YC ( lanes 5, 13, 22, and 26) , anti-NF-1 (lanes 6 and 14) , anti-CEBP ( lanes  7 and 15) , anti-GATA-1 (lanes 8 and 16) , and control IgG (lanes 9 and 17). Control assays were performed without nuclear extract and antibody (lanes 1 and 18), and with nuclear extracts but without antibody (lanes 2, 10, 19, and 23). UAS CCAAT box (41, 42) . It was purified independently using affinity columns containing the Y box, the ␣2(I) collagen CCAAT, and the ␣-globin CCAAT sequence (36, 43, 44) . CBF/ NF-Y is a ubiquitous heterotrimer composed of three subunits, CBF-A/NF-YB, CBF-B/NF-YA, and CBF-C/NF-YC, all necessary for DNA binding (45) . CBF/NF-Y requires the perfect pentanucleotide, CCAAT, except in a few genes (46) . For CBF/ NF-Y to bind to the CCAAT motif, three 5Ј (C, Pu, Pu) and five 3Ј (C/G, A/G, G, A/C, G) flanking nucleotides also appear to be important (Fig. 12A) . These 5Ј-and 3Ј-flanking sequences are conserved in COL5A3 except one for nucleotide at the 3Ј-flanking region.
One of the repressors might bind to the E-box, located at Ϫ83 to Ϫ78 bp, in the core promoter region of COL5A3. The factor binding to the E-box usually works as an activator, such as MyoD (47) . One of the factors for the specific expression of mouse Col1a1 in tendon fibroblasts binds to the E-box located between Ϫ3.2 and Ϫ2.3 kb (48) . The E-box in the 3Ј-flanking region is also involved in the stimulation of transcription of Col1a1 (49) . The E2-box, a subset of the E-box, has a ciselement containing both activator and repressor binding sites. The ␦EF1, which is a zinc finger protein, bound to Ϫ307 to Ϫ100 bp in the promoter of rat Col2a1 gene, and repressed its transcription (50). Seki et al. (51) reported that, in the snail and slug, the C2H2 type zinc finger protein suppressed the promoter activity of Col2a1, and that four E-box up to the Ϫ1,000 bp from the transcription start site were responsible with the additive efficiency. Other putative suppressors bound to Ϫ101 to Ϫ96 bp were also examined with the competition assay using the oligonucleotide motifs of known factors. The results showed neither c-Myb nor CEBP, which were candidate factors predicted from a computer search. c-Myb could transactivate the COL1A2 gene by binding at around Ϫ1,025 bp, whereas B-Myb, which has a similar structure, could not (52) . B-Myb repressed the transcription of both type I collagen genes (53) and COL5A2 (24) . The Myb family may have a role in the regulation of COL5A3.
Heterotrimer ␣1(V)␣2(V)␣3(V) molecules were originally extracted from human placenta (10 -12) . The ␣3(V) chain was also isolated from synovial membrane, gingival, skin (11) , and uterus (54) . In situ hybridization of mouse embryo detects ␣3(V) expression in the epimysial sheaths of developing muscles and within nascent ligaments adjacent to forming bones and in joints (16). Chernousov et al. (55) reported the isolation of heparin sulfate-binding collagenous protein, p200, which is expressed by Schwann cells in developing peripheral nerves. They named the rat ␣4(V) chain that shows 82% amino acid sequence identity to human ␣3(V) chain (15) . In our experiment, human ␣3(V) chain is expressed in the Schwann cell line, YST-1. The expression of ␣3(V) chain is less abundant compared with ␣1(V) chain, but distributed in many more tissues than previously expected. The [␣1(V)] 2 ␣2(V) form is the only one whose tissue distribution and supramolecular organization has been extensively studied. It is usually co-expressed with type I collagen and forms type I/V heterotypic fibrils. The nature of the ␣1(V)␣2(V)␣3(V) form has remained relatively obscure. Our previous study suggested that CBF/NF-Y is required for the coordinated expression of the ␣1(V) gene and both type I collagen genes (26) . In this study, we showed that it binds to the COL5A3 promoter. Penkov et al. (23) identified PBX1/2, PREP1, and HOXB1 proteins as an FPB-bound complex in the proximal COL5A2 promoter. Although they did not recognize a cis-acting element that binds CBF/NF-Y, it may exist in some region of the COL5A2 promoter.
In fibrillar collagen genes, the expression of the type II collagen gene is clearly different from those of type I collagen genes. The promoter of the ␣1(II) gene has a weak activity, and the tissue-specific expression is regulated by the enhancer region in the first intron, where the Sox family binds (56) . Although type III collagen is coordinately expressed with type I collagen in fetal tissues and blood vessels, the mechanism of regulation seems to be different from those of type I collagen genes. Two distinct positive factors, one of which is a heat-resistant protein of ϳ95 kDa, bind in the proximal promoter of the Col3a1 gene (57) . CBF/NF-Y itself is a ubiquitous transactivating factor; therefore, it may be utilized for the broad expression in noncartilaginous tissue such as type I and V collagen genes. However, it is difficult to explain the decrease in promoter activity from Ϫ129 to Ϫ40 bp by the sole involvement of CBF/NF-Y because the dominant negative mutant of CBF-B/NF-YA was partially suppressed (Fig. 11) . Other activators that could not be identified under the conditions of our system might bind in this region. On the contrary, we showed two repressors in this region instead of activators (Fig. 12B) . The identification of factors other than CBF/NF-Y should provide further information on the type V collagen expression, followed by characterization of different roles for the isoforms of type V collagen.
